Evidence map›Paper›PMID 24757216›Full record

ArticlemBio2014

Global population structure and evolution of Bordetella pertussis and their relationship with vaccination.

Marieke J Bart, Simon R Harris, Abdolreza Advani, Yoshichika Arakawa, Daniela Bottero, Valérie Bouchez, Pamela K Cassiday, Chuen-Sheue Chiang, Tine Dalby, Norman K Fry and 28 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in mBio, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 173 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
173citing papers in PubMed, 1 pooled it
25.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

173 citing papers in PubMed, 1 synthesis or guideline pooled it, 313 citations in OpenAlex.

  1. Pertactin deficiency ofHuman vaccines & immunotherapeutics · 2024
    Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Vaccines · 2026
    Review
  10. Article
  11. Macrolide resistance trajectories across threeFrontiers in microbiology · 2026
    Article
  12. Review
  13. Genomic epidemiology and evolution ofEmerging microbes & infections · 2025
    Article
  14. Article
  15. Draft genome sequence ofMicrobiology resource announcements · 2025
    Article
  16. Proteomic comparison of epidemic AustralianMicrobiology spectrum · 2025
    Article
  17. Article
  18. Article
  19. Review
  20. Resurgence of pertussis: whopping the '100-day cough'.Current opinion in pediatrics · 2025
    Review

113 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors at 20 institutions in 15 countries.

Marieke J Bart
Simon R Harris
Abdolreza Advani
Yoshichika Arakawa
Daniela Bottero
Valérie Bouchez
Pamela K Cassiday
Chuen-Sheue Chiang
Tine Dalby
Norman K Fry
María Emilia Gaillard
Marjolein van Gent
Nicole Guiso
Hans O Hallander
Eric T Harvill
Qiushui He
Han G J van der Heide
Kees Heuvelman
Daniela F Hozbor
Kazunari Kamachi
Gennady I Karataev
Ruiting Lan
Anna Lutyńska
Ram P Maharjan
Jussi Mertsola
Tatsuo Miyamura
Sophie Octavia
Andrew Preston
Michael A Quail
Vitali Sintchenko
Paola Stefanelli
M Lucia Tondella
Raymond S W Tsang
Yinghua Xu
Shu-Man Yao
Shumin Zhang
Julian Parkhill
Frits R Mooi
National Institute for Public Health and the Environment · NLNational Institute of Infectious Diseases · JPUNSW Sydney · AUWellcome Sanger Institute · GBNational Institutes for Food and Drug Control · CNSwedish Institute · SEUniversidad Nacional de La Plata · ARCenters for Disease Control and Prevention · USCentre National de la Recherche Scientifique · FRConsejo Nacional de Investigaciones Científicas y Técnicas · ARFinnish Institute for Health and Welfare · FIInstitut Pasteur · FRIstituto Superiore di Sanità · ITMinistry of Health of the Russian Federation · RUNarodowy Instytut Zdrowia Publicznego PZH – Państwowy Instytut Badawczy · PLNational Center for Immunization and Respiratory Diseases · USPennsylvania State University · USPublic Health Agency of Canada · CAPublic Health England · GBStatens Serum Institut · DK

Funding

Evolution of the Bordetellae from Commensals to PathogensR01GM083113 · NIGMS · PENNSYLVANIA STATE UNIVERSITY, THE · PI HARVILL, ERIC T · 2008 to 2011
$2.1M
The Microbiota Pathogen CompetitionR01GM113681 · NIGMS · UNIVERSITY OF GEORGIA · PI HARVILL, ERIC T · 2015 to 2018
$1.3M
NIGMS NIH HHS R01 GM083113NIGMS NIH HHS R01 GM113681Wellcome TrustWellcome Trust 098051
6 · The paper itself

Abstract

Bordetella pertussis causes pertussis, a respiratory disease that is most severe for infants. Vaccination was introduced in the 1950s, and in recent years, a resurgence of disease was observed worldwide, with significant mortality in infants. Possible causes for this include the switch from whole-cell vaccines (WCVs) to less effective acellular vaccines (ACVs), waning immunity, and pathogen adaptation. Pathogen adaptation is suggested by antigenic divergence between vaccine strains and circulating strains and by the emergence of strains with increased pertussis toxin production. We applied comparative genomics to a worldwide collection of 343 B. pertussis strains isolated between 1920 and 2010. The global phylogeny showed two deep branches; the largest of these contained 98% of all strains, and its expansion correlated temporally with the first descriptions of pertussis outbreaks in Europe in the 16th century. We found little evidence of recent geographical clustering of the strains within this lineage, suggesting rapid strain flow between countries. We observed that changes in genes encoding proteins implicated in protective immunity that are included in ACVs occurred after the introduction of WCVs but before the switch to ACVs. Furthermore, our analyses consistently suggested that virulence-associated genes and genes coding for surface-exposed proteins were involved in adaptation. However, many of the putative adaptive loci identified have a physiological role, and further studies of these loci may reveal less obvious ways in which B. pertussis and the host interact. This work provides insight into ways in which pathogens may adapt to vaccination and suggests ways to improve pertussis vaccines. IMPORTANCE Whooping cough is mainly caused by Bordetella pertussis, and current vaccines are targeted against this organism. Recently, there have been increasing outbreaks of whooping cough, even where vaccine coverage is high. Analysis of the genomes of 343 B. pertussis isolates from around the world over the last 100 years suggests that the organism has emerged within the last 500 years, consistent with historical records. We show that global transmission of new strains is very rapid and that the worldwide population of B. pertussis is evolving in response to vaccine introduction, potentially enabling vaccine escape.

Indexed as

Adaptation, BiologicalBordetella pertussisCluster AnalysisCommunicable Diseases, EmergingEvolution, MolecularGenome, BacterialGlobal HealthHumansInfantPertussis VaccinePhylogenyVaccinationWhooping CoughPertussis Vaccine

Identifiers

PMID24757216
PMCPMC3994516
OpenAlexW2032638170

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.